Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Alethia Young's Stock Ratings
Cantor Fitzgerald Analyst
Alethia Young is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/18/2025
Updated: Dec 18, 2025
Overall Average Return
30.7%
Smart Score
Overall Average Return Percentile
86th
Number of Ratings
202
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/05/2024 | RCUS | Buy Now | Arcus Biosciences | $22.49 | — | — | Reiterates | → Overweight | Get Alert | |
| 06/20/2024 | ARWR | Buy Now | Arrowhead Pharma | $65.70 | — | — | Reiterates | → Overweight | Get Alert | |
| 10/16/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | 14.4% | $800 → $850 | Maintains | Neutral | Get Alert | |
| 09/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | 7.67% | → $800 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/12/2023 | RCUS | Buy Now | Arcus Biosciences | $22.49 | 104.54% | → $46 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/12/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.36 | 1223.53% | → $18 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | RCUS | Buy Now | Arcus Biosciences | $22.49 | 104.54% | → $46 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | CRIS | Buy Now | Curis | $1.17 | 156.41% | → $3 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.36 | 1223.53% | → $18 | Reinstates | Overweight → Overweight | Get Alert | |
| 08/22/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | → $16 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/22/2023 | ELDN | Buy Now | Eledon Pharma | $1.60 | 462.5% | → $9 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/14/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.36 | 1223.53% | $22 → $18 | Maintains | Overweight | Get Alert | |
| 08/11/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.36 | 1223.53% | $22 → $18 | Maintains | Overweight | Get Alert | |
| 08/08/2023 | ARWR | Buy Now | Arrowhead Pharma | $65.70 | -28.46% | $79 → $47 | Maintains | Overweight | Get Alert | |
| 07/24/2023 | ALXO | Buy Now | ALX Oncology Holdings | $1.36 | 1517.65% | → $22 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/14/2023 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | $23 → $7 | Maintains | Overweight | Get Alert | |
| 07/12/2023 | RCUS | Buy Now | Arcus Biosciences | $22.49 | 104.54% | → $46 | Reinstates | Overweight → Overweight | Get Alert | |
| 07/11/2023 | CRIS | Buy Now | Curis | $1.17 | 156.41% | → $3 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/06/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | 7% | $815 → $795 | Maintains | Neutral | Get Alert | |
| 07/06/2023 | VSTM | Buy Now | Verastem | $9.01 | 277.36% | → $34 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/06/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | → $16 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/27/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | → $16 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/23/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | 9.69% | → $815 | Reiterates | Neutral → Neutral | Get Alert | |
| 06/20/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | 9.69% | → $815 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/11/2023 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | $11 → $16 | Maintains | Overweight | Get Alert | |
| 11/16/2022 | NEXI | Buy Now | NexImmune | $0.01 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 12/21/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $93 → $100 | Downgrade | Overweight → Neutral | Get Alert | |
| 11/01/2021 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | → $25 | Initiates | → Overweight | Get Alert | |
| 10/15/2021 | BIIB | Buy Now | Biogen | $172.10 | 90.01% | $427 → $327 | Maintains | Neutral | Get Alert | |
| 08/10/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $100 → $93 | Maintains | Overweight | Get Alert | |
| 07/23/2021 | ADVM | Buy Now | Adverum Biotechnologies | $4.60 | -34.78% | $23 → $3 | Downgrade | Overweight → Neutral | Get Alert | |
| 06/14/2021 | RAPT | Buy Now | RAPT Therapeutics | $33.18 | 113.98% | $51 → $71 | Maintains | Overweight | Get Alert | |
| 06/11/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $450.31 | -37.6% | $285 → $281 | Maintains | Overweight | Get Alert | |
| 04/09/2021 | PRVB | Buy Now | Provention Bio | — | — | $27 → $25 | Maintains | Overweight | Get Alert | |
| 04/06/2021 | LBPH | Buy Now | Longboard Pharmaceuticals | — | — | → $32 | Initiates | → Overweight | Get Alert | |
| 03/23/2021 | ELDN | Buy Now | Eledon Pharma | $1.60 | 1462.5% | → $25 | Initiates | → Overweight | Get Alert | |
| 03/09/2021 | NEXI | Buy Now | NexImmune | $0.01 | 349900% | → $35 | Initiates | → Overweight | Get Alert | |
| 03/08/2021 | AKBA | Buy Now | Akebia Therapeutics | $1.61 | 396.89% | → $8 | Initiates | → Overweight | Get Alert | |
| 03/03/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $106 → $100 | Maintains | Overweight | Get Alert | |
| 02/25/2021 | FATE | Buy Now | Fate Therapeutics | $1.07 | 9058.88% | $86 → $98 | Maintains | Overweight | Get Alert | |
| 02/17/2021 | BIIB | Buy Now | Biogen | $172.10 | 55.72% | $278 → $268 | Maintains | Neutral | Get Alert | |
| 02/16/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | -11.71% | $696 → $656 | Maintains | Overweight | Get Alert | |
| 02/03/2021 | AMGN | Buy Now | Amgen | $327.00 | -9.79% | $280 → $295 | Maintains | Overweight | Get Alert | |
| 12/14/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $147 → $194 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/29/2020 | GILD | Buy Now | Gilead Sciences | $121.27 | -29.08% | $84 → $86 | Reiterates | → Overweight | Get Alert | |
| 10/29/2020 | AMGN | Buy Now | Amgen | $327.00 | -14.98% | $279 → $278 | Reiterates | → Overweight | Get Alert | |
| 10/28/2020 | TGTX | Buy Now | TG Therapeutics | $31.14 | 54.13% | $30 → $48 | Maintains | Overweight | Get Alert | |
| 10/12/2020 | BCYC | Buy Now | Bicycle Therapeutics | $6.95 | 331.65% | → $30 | Initiates | → Overweight | Get Alert | |
| 10/05/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | -7.13% | → $690 | Upgrade | Neutral → Overweight | Get Alert | |
| 08/19/2020 | GILD | Buy Now | Gilead Sciences | $121.27 | -30.73% | $86 → $84 | Maintains | Overweight | Get Alert | |
| 08/13/2020 | FATE | Buy Now | Fate Therapeutics | $1.07 | 3638.32% | $32 → $40 | Maintains | Overweight | Get Alert | |
| 08/11/2020 | ALXO | Buy Now | ALX Oncology Holdings | $1.36 | 4605.88% | → $64 | Initiates | → Overweight | Get Alert | |
| 07/31/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 176.82% | $70 → $72 | Maintains | Overweight | Get Alert | |
| 07/31/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $450.31 | -32.27% | $293 → $305 | Maintains | Overweight | Get Alert | |
| 07/29/2020 | AMGN | Buy Now | Amgen | $327.00 | -14.68% | $263 → $279 | Maintains | Overweight | Get Alert | |
| 07/28/2020 | SPPI | Buy Now | Spectrum Pharma | — | — | $4 → $7 | Maintains | Neutral | Get Alert | |
| 07/27/2020 | RAPT | Buy Now | RAPT Therapeutics | $33.18 | 53.71% | $37 → $51 | Maintains | Overweight | Get Alert | |
| 07/17/2020 | CRIS | Buy Now | Curis | $1.17 | 241.88% | → $4 | Initiates | → Overweight | Get Alert | |
| 06/30/2020 | ICPT | Buy Now | Intercept Pharma | — | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 06/02/2020 | PACB | Buy Now | Pacific Biosciences | $1.98 | 152.51% | → $5 | Assumes | → Overweight | Get Alert | |
| 06/01/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $142 → $147 | Maintains | Outperform | Get Alert | |
| 05/19/2020 | INCY | Buy Now | Incyte | $98.86 | 1.15% | $83 → $100 | Maintains | Neutral | Get Alert | |
| 05/08/2020 | ARWR | Buy Now | Arrowhead Pharma | $65.70 | -11.72% | $60 → $58 | Reiterates | → Overweight | Get Alert | |
| 05/08/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $56 → $68 | Reiterates | → Overweight | Get Alert | |
| 05/06/2020 | TGTX | Buy Now | TG Therapeutics | $31.14 | 12.39% | $19 → $35 | Maintains | Overweight | Get Alert | |
| 05/05/2020 | MRNS | Buy Now | Marinus Pharma | — | — | $7 → $6 | Reiterates | → Overweight | Get Alert | |
| 05/04/2020 | STML | Buy Now | Stemline Therapeutics | — | — | $10 → $12.5 | Downgrade | Overweight → Neutral | Get Alert | |
| 05/04/2020 | AMGN | Buy Now | Amgen | $327.00 | -19.57% | $255 → $263 | Reiterates | → Overweight | Get Alert | |
| 05/01/2020 | BIIB | Buy Now | Biogen | $172.10 | 78.97% | $361 → $308 | Reiterates | → Neutral | Get Alert | |
| 04/20/2020 | ASND | Buy Now | Ascendis Pharma | $202.82 | -0.9% | $185 → $201 | Reiterates | → Overweight | Get Alert | |
| 04/15/2020 | ARWR | Buy Now | Arrowhead Pharma | $65.70 | -8.68% | → $60 | Upgrade | Neutral → Overweight | Get Alert | |
| 04/08/2020 | PTCT | Buy Now | PTC Therapeutics | $75.12 | 13.15% | $86 → $85 | Reiterates | → Overweight | Get Alert | |
| 04/07/2020 | GILD | Buy Now | Gilead Sciences | $121.27 | -29.08% | $78 → $86 | Reiterates | → Overweight | Get Alert | |
| 04/03/2020 | RCUS | Buy Now | Arcus Biosciences | $22.49 | -6.63% | → $21 | Initiates | → Overweight | Get Alert | |
| 03/27/2020 | STML | Buy Now | Stemline Therapeutics | — | — | $18 → $10 | Reiterates | → Overweight | Get Alert | |
| 03/11/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $450.31 | -38.93% | $262 → $275 | Reiterates | → Overweight | Get Alert | |
| 03/09/2020 | PACB | Buy Now | Pacific Biosciences | $1.98 | 152.51% | → $5 | Assumes | → Overweight | Get Alert | |
| 03/06/2020 | AUPH | Buy Now | Aurinia Pharmaceuticals | $16.00 | 100% | $30 → $32 | Maintains | Overweight | Get Alert | |
| 03/03/2020 | VSTM | Buy Now | Verastem | $9.01 | -33.41% | $3 → $6 | Maintains | Overweight | Get Alert | |
| 03/03/2020 | PTCT | Buy Now | PTC Therapeutics | $75.12 | 14.48% | $81 → $86 | Reiterates | → Overweight | Get Alert | |
| 02/27/2020 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 906.96% | $211 → $217 | Reiterates | → Overweight | Get Alert | |
| 02/27/2020 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | $62 → $56 | Reiterates | → Overweight | Get Alert | |
| 02/14/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 169.13% | $64 → $70 | Reiterates | → Overweight | Get Alert | |
| 02/10/2020 | ADVM | Buy Now | Adverum Biotechnologies | $4.60 | 356.52% | $8 → $21 | Upgrade | Neutral → Overweight | Get Alert | |
| 02/06/2020 | BIIB | Buy Now | Biogen | $172.10 | 109.76% | $315 → $361 | Reiterates | → Neutral | Get Alert | |
| 02/06/2020 | ARWR | Buy Now | Arrowhead Pharma | $65.70 | -16.29% | $50 → $55 | Maintains | Neutral | Get Alert | |
| 01/24/2020 | PRVB | Buy Now | Provention Bio | — | — | → $25 | Initiates | → Overweight | Get Alert | |
| 01/23/2020 | PTCT | Buy Now | PTC Therapeutics | $75.12 | 7.83% | $60 → $81 | Maintains | Overweight | Get Alert | |
| 01/23/2020 | INCY | Buy Now | Incyte | $98.86 | -16.04% | $65 → $83 | Maintains | Neutral | Get Alert | |
| 01/03/2020 | INCY | Buy Now | Incyte | $98.86 | -34.25% | $75 → $65 | Maintains | Neutral | Get Alert | |
| 12/26/2019 | SPPI | Buy Now | Spectrum Pharma | — | — | $17 → $4 | Downgrade | Overweight → Neutral | Get Alert | |
| 12/24/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 758.47% | $190 → $185 | Maintains | Outperform | Get Alert | |
| 12/24/2019 | STML | Buy Now | Stemline Therapeutics | — | — | → $18 | Initiates | → Overweight | Get Alert | |
| 12/13/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 879.12% | $175 → $211 | Maintains | Overweight | Get Alert | |
| 12/13/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 781.67% | $185 → $190 | Maintains | Outperform | Get Alert | |
| 11/26/2019 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 146.06% | → $64 | Initiates | → Overweight | Get Alert | |
| 11/19/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $450.31 | -49.15% | $217 → $229 | Maintains | Overweight | Get Alert | |
| 11/14/2019 | TGTX | Buy Now | TG Therapeutics | $31.14 | -38.99% | $20 → $19 | Maintains | Overweight | Get Alert | |
| 11/08/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 758.47% | $201 → $185 | Maintains | Outperform | Get Alert | |
| 11/05/2019 | AMGN | Buy Now | Amgen | $327.00 | -22.02% | $230 → $255 | Upgrade | Neutral → Overweight | Get Alert | |
| 10/18/2019 | MRNS | Buy Now | Marinus Pharma | — | — | → $7 | Assumes | → Overweight | Get Alert | |
| 10/15/2019 | RARX | Buy Now | Ra Pharmaceuticals | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 10/03/2019 | ANAB | Buy Now | AnaptysBio | $45.69 | 5.06% | $75 → $48 | Maintains | Neutral | Get Alert | |
| 09/06/2019 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $154 → $146 | Maintains | Outperform | Get Alert | |
| 09/05/2019 | AMGN | Buy Now | Amgen | $327.00 | -29.66% | $221 → $230 | Reiterates | → Neutral | Get Alert | |
| 08/20/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 832.71% | $207 → $201 | Maintains | Outperform | Get Alert | |
| 07/22/2019 | FATE | Buy Now | Fate Therapeutics | $1.07 | 2890.65% | → $32 | Initiates | → Overweight | Get Alert | |
| 06/21/2019 | ANAB | Buy Now | AnaptysBio | $45.69 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 05/13/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | -45.49% | $441 → $405 | Maintains | Neutral | Get Alert | |
| 03/29/2019 | ASND | Buy Now | Ascendis Pharma | $202.82 | -31.47% | $151 → $139 | Maintains | Outperform | Get Alert | |
| 03/29/2019 | TGTX | Buy Now | TG Therapeutics | $31.14 | — | — | Initiates | → Overweight | Get Alert | |
| 03/21/2019 | BIIB | Buy Now | Biogen | $172.10 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 02/28/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 971.93% | $217 → $231 | Maintains | Overweight | Get Alert | |
| 02/07/2019 | SPPI | Buy Now | Spectrum Pharma | — | — | → $19 | Initiates | → Overweight | Get Alert | |
| 01/24/2019 | ASND | Buy Now | Ascendis Pharma | $202.82 | -49.71% | → $102 | Initiates | → Overweight | Get Alert | |
| 11/12/2018 | PTCT | Buy Now | PTC Therapeutics | $75.12 | -18.8% | $66 → $61 | Maintains | Overweight | Get Alert | |
| 11/12/2018 | PACB | Buy Now | Pacific Biosciences | $1.98 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 11/05/2018 | ADVM | Buy Now | Adverum Biotechnologies | $4.60 | -13.04% | $12 → $4 | Downgrade | Overweight → Neutral | Get Alert | |
| 10/22/2018 | INCY | Buy Now | Incyte | $98.86 | -25.15% | $73 → $74 | Maintains | Neutral | Get Alert | |
| 10/01/2018 | BIIB | Buy Now | Biogen | $172.10 | 132.42% | → $400 | Reinstates | → Overweight | Get Alert | |
| 10/01/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $743.00 | -44.15% | → $415 | Initiates | → Neutral | Get Alert | |
| 10/01/2018 | AMGN | Buy Now | Amgen | $327.00 | -31.8% | → $223 | Initiates | → Neutral | Get Alert | |
| 10/01/2018 | INCY | Buy Now | Incyte | $98.86 | -26.16% | → $73 | Initiates | → Neutral | Get Alert | |
| 10/01/2018 | PTCT | Buy Now | PTC Therapeutics | $75.12 | -12.14% | → $66 | Initiates | → Overweight | Get Alert | |
| 09/21/2018 | ADVM | Buy Now | Adverum Biotechnologies | $4.60 | 160.87% | → $12 | Initiates | → Overweight | Get Alert | |
| 09/06/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 725.99% | → $178 | Initiates | → Outperform | Get Alert | |
| 08/09/2018 | PACB | Buy Now | Pacific Biosciences | $1.98 | 152.51% | → $5 | Initiates | → Overweight | Get Alert | |
| 08/07/2018 | RARX | Buy Now | Ra Pharmaceuticals | — | — | $14 → $17 | Maintains | Outperform | Get Alert | |
| 07/19/2018 | ANAB | Buy Now | AnaptysBio | $45.69 | 127.62% | → $104 | Initiates | → Outperform | Get Alert | |
| 07/02/2018 | MRNS | Buy Now | Marinus Pharma | — | — | → $19 | Initiates | → Overweight | Get Alert | |
| 06/05/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $149 → $154 | Maintains | Outperform | Get Alert | |
| 05/04/2018 | TSRO | Buy Now | Tesaro | — | — | $141 → $128 | Maintains | Outperform | Get Alert | |
| 05/04/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 326.91% | $100 → $92 | Maintains | Outperform | Get Alert | |
| 04/11/2018 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 265.24% | $80 → $95 | Maintains | Outperform | Get Alert | |
| 04/09/2018 | INCY | Buy Now | Incyte | $98.86 | -21.1% | $145 → $78 | Maintains | Outperform | Get Alert | |
| 03/22/2018 | MESO | Buy Now | Mesoblast | $19.00 | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 03/20/2018 | ASND | Buy Now | Ascendis Pharma | $202.82 | -61.54% | $50 → $78 | Maintains | Outperform | Get Alert | |
| 03/16/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $147 → $149 | Maintains | Outperform | Get Alert | |
| 03/13/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 364.04% | $81 → $100 | Maintains | Outperform | Get Alert | |
| 03/13/2018 | ALNY | Buy Now | Alnylam Pharmaceuticals | $392.10 | -60.72% | $151 → $154 | Maintains | Outperform | Get Alert | |
| 03/02/2018 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.47 | 121.08% | $113 → $116 | Maintains | Outperform | Get Alert | |
| 02/28/2018 | TSRO | Buy Now | Tesaro | — | — | $150 → $141 | Maintains | Outperform | Get Alert | |
| 02/28/2018 | CELG | Buy Now | Celgene | — | — | $130 → $129 | Maintains | Outperform | Get Alert | |
| 02/15/2018 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 207.57% | $66 → $80 | Maintains | Outperform | Get Alert | |
| 02/13/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $450.31 | -56.47% | $195 → $196 | Maintains | Outperform | Get Alert | |
| 02/13/2018 | RARX | Buy Now | Ra Pharmaceuticals | — | — | $16 → $14 | Maintains | Outperform | Get Alert | |
| 02/07/2018 | ABC | Buy Now | AmerisourceBergen | — | — | $105 → $112 | Maintains | Outperform | Get Alert | |
| 02/02/2018 | AMGN | Buy Now | Amgen | $327.00 | -40.67% | $191 → $194 | Maintains | Neutral | Get Alert | |
| 01/24/2018 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 1849.68% | $147 → $106 | Maintains | Outperform | Get Alert | |
| 01/24/2018 | BIVV | Buy Now | Bioverativ | — | — | $65 → $105 | Maintains | Neutral | Get Alert | |
| 01/18/2018 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | → $147 | Assumes | → Outperform | Get Alert | |
| 11/14/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | $35 → $51 | Maintains | Outperform | Get Alert | |
| 11/10/2017 | RARX | Buy Now | Ra Pharmaceuticals | — | — | $19 → $23 | Maintains | Outperform | Get Alert | |
| 11/10/2017 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 2511.83% | $136 → $142 | Maintains | Outperform | Get Alert | |
| 11/03/2017 | NTLA | Buy Now | Intellia Therapeutics | $9.01 | 210.77% | $24 → $28 | Maintains | Outperform | Get Alert | |
| 11/03/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $392.10 | -61.49% | $123 → $151 | Maintains | Outperform | Get Alert | |
| 11/02/2017 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 153.75% | $61 → $66 | Maintains | Outperform | Get Alert | |
| 10/19/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.47 | 136.33% | $114 → $124 | Maintains | Outperform | Get Alert | |
| 09/29/2017 | AMGN | Buy Now | Amgen | $327.00 | -43.12% | $177 → $186 | Maintains | Outperform | Get Alert | |
| 09/27/2017 | DRI | Buy Now | Darden Restaurants | $198.00 | -58.59% | $85 → $82 | Maintains | Neutral | Get Alert | |
| 09/22/2017 | ASND | Buy Now | Ascendis Pharma | $202.82 | -75.35% | $30 → $50 | Maintains | Outperform | Get Alert | |
| 09/21/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $392.10 | -68.63% | $96 → $123 | Maintains | Outperform | Get Alert | |
| 09/11/2017 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 2401.47% | $118 → $136 | Maintains | Outperform | Get Alert | |
| 09/07/2017 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | 275.87% | $64 → $81 | Maintains | Outperform | Get Alert | |
| 08/25/2017 | ANAB | Buy Now | AnaptysBio | $45.69 | -16.83% | $34 → $38 | Maintains | Outperform | Get Alert | |
| 08/18/2017 | TSRO | Buy Now | Tesaro | — | — | $198 → $190 | Maintains | Outperform | Get Alert | |
| 07/18/2017 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 2070.39% | $90 → $118 | Maintains | Outperform | Get Alert | |
| 05/24/2017 | BIVV | Buy Now | Bioverativ | — | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 03/16/2017 | UTHR | Buy Now | United Therapeutics | $511.15 | — | — | Initiates | → Underperform | Get Alert | |
| 03/16/2017 | BIVV | Buy Now | Bioverativ | — | — | → $45 | Initiates | → Underperform | Get Alert | |
| 02/09/2017 | ASND | Buy Now | Ascendis Pharma | $202.82 | -86.19% | → $28 | Initiates | → Outperform | Get Alert | |
| 12/16/2016 | BIIB | Buy Now | Biogen | $172.10 | 70.25% | → $293 | Initiates | → Neutral | Get Alert | |
| 11/29/2016 | DRI | Buy Now | Darden Restaurants | $198.00 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/21/2016 | RARX | Buy Now | Ra Pharmaceuticals | — | — | → $19 | Initiates | → Outperform | Get Alert | |
| 10/18/2016 | SRPT | Buy Now | Sarepta Therapeutics | $21.55 | — | — | Initiates | → Outperform | Get Alert | |
| 10/18/2016 | ACIU | Buy Now | AC Immune | $2.94 | — | — | Initiates | → Outperform | Get Alert | |
| 10/10/2016 | TSRO | Buy Now | Tesaro | — | — | — | Maintains | Outperform | Get Alert | |
| 10/06/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $392.10 | -87.25% | $145 → $50 | Maintains | Outperform | Get Alert | |
| 09/22/2016 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 1941.64% | $54 → $111 | Maintains | Outperform | Get Alert | |
| 07/11/2016 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $186 → $165 | Upgrade | Neutral → Outperform | Get Alert | |
| 06/14/2016 | MESO | Buy Now | Mesoblast | $19.00 | -73.68% | $10 → $5 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/18/2016 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 169.13% | $65 → $70 | Maintains | Outperform | Get Alert | |
| 05/13/2016 | TSRO | Buy Now | Tesaro | — | — | → $56 | Initiates | → Outperform | Get Alert | |
| 04/19/2016 | CELG | Buy Now | Celgene | — | — | $144 → $140 | Maintains | Outperform | Get Alert | |
| 03/29/2016 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 819.66% | $69 → $50 | Maintains | Outperform | Get Alert | |
| 02/11/2016 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 1169.13% | → $69 | Initiates | → Outperform | Get Alert | |
| 01/29/2016 | CELG | Buy Now | Celgene | — | — | $97.21 → $144 | Maintains | Outperform | Get Alert | |
| 01/20/2016 | PBYI | Buy Now | Puma Biotechnology | $5.44 | 1169.13% | → $69 | Initiates | → Outperform | Get Alert | |
| 01/20/2016 | AGIO | Buy Now | Agios Pharmaceuticals | $26.01 | 188.35% | → $75 | Initiates | → Outperform | Get Alert | |
| 01/20/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $392.10 | -60.72% | → $154 | Initiates | → Outperform | Get Alert | |
| 01/20/2016 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | → $201 | Initiates | → Neutral | Get Alert | |
| 01/20/2016 | MESO | Buy Now | Mesoblast | $19.00 | -47.37% | → $10 | Initiates | → Outperform | Get Alert | |
| 01/20/2016 | CELG | Buy Now | Celgene | — | — | → $149 | Initiates | → Outperform | Get Alert | |
| 08/27/2015 | PACB | Buy Now | Pacific Biosciences | $1.98 | 354.52% | → $9 | Initiates | → Buy | Get Alert | |
| 10/22/2014 | CELG | Buy Now | Celgene | — | — | $113 → $125 | Maintains | Outperform | Get Alert | |
| 07/25/2014 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | $174 → $179 | Maintains | Neutral | Get Alert | |
| 07/25/2014 | CELG | Buy Now | Celgene | — | — | $112.5 → $113 | Maintains | Outperform | Get Alert | |
| 06/19/2014 | CELG | Buy Now | Celgene | — | — | $210 → $225 | Maintains | Outperform | Get Alert | |
| 12/10/2013 | CELG | Buy Now | Celgene | — | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 05/31/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | → $110 | Initiates | → Neutral | Get Alert | |
| 04/04/2013 | CELG | Buy Now | Celgene | — | — | $110 → $125 | Maintains | Neutral | Get Alert | |
| 03/04/2013 | CELG | Buy Now | Celgene | — | — | $85 → $110 | Maintains | Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved